Platform
Features
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.
Industries
Headquarters
Stage
Employees
Links
Kenneth Galbraith
53 members
18 members
6 members
14 members
9 members
View all
Schrödinger
8 followers
Verve Therapeutics
54 followers
Recursion Pharmaceuticals
6 followers
AbCellera
1 follower
BlueRock Therapeutics
AxoGen
BioAgilytix
Wealthsimple
74 followers
AbSci
Omada Health
15 followers
Ada
12 followers
Discover companies